增强基因传递效率,使用被米里斯酸和三级氨基群修改的两基
Emine Büşra Eker Fidan1, Kevser Bal1, Sema Şentürk1
1Istanbul University-Cerrahpasa, Faculty of Engineering, Department of Chemical Engineering, Istanbul, Turkey.
International journal of biological macromolecules
|October 23, 2024
概括
研究人员开发了新的两性奇托桑纳米颗粒 (Chi-MA) 进行高效的基因传递. 这些生物相容的纳米颗粒显示出高的转染效率和无毒性,标志着非病毒基因载体的显著进步.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 基因治疗 基因治疗
背景情况:
- 酸盐是药物和基因输送的有前途的生物材料,因为它具有生物相容性和生物降解性.
- 开发高效且无毒的非病毒基因载体仍然是基因疗法的关键挑战.
- 两性修改可以增强酸盐的特性,以改善基因传递应用.
研究的目的:
- 为了合成和表征新的两性奇多纳米颗粒 (Chi-MA) 与酸和三级氨基基团.
- 评估基因传递效率,包括复杂化能力,质子缓冲和转染效率.
- 在HEK293T细胞上评估开发的Chi-MA纳米颗粒的细胞毒性.
主要方法:
- 通过用米里斯酸和3-dimethylamino-1-propyl化物化物对基酸进行修改,对两性基酸 (Chi-MA) 的化学合成.
- 使用NMR,FTIR和GPC-SEC进行表征;通过离子凝制备纳米粒子.
- 评估颗粒大小,多分散性,泽塔潜力,质子缓冲能力,基因复杂化能力,细胞毒性 (MTT检测) 和转染效率 (流细胞计).
主要成果:
- 成功合成和表征了具有增强纳米粒子形成能力和基因复杂化能力增加8倍的Chi-MA纳米粒子.
- 奇-MA纳米颗粒对HEK293T细胞没有显著的细胞毒性.
- 与之前的研究相比,在显著较低的纳米粒子:基因比率下实现了高的转染效率.
结论:
- 两性Chi-MA纳米颗粒是一种高效且无毒的非病毒基因传递系统.
- 开发的Chi-MA配方显示出优越的基因复杂化和转染能力.
- 这项研究强调了改性素作为下一代基因载体的治疗应用潜力.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


